Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVolex Regulatory News (VLX)

Share Price Information for Volex (VLX)

Share Price is delayed by 15 minutes
Get Live Data
626.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 2.00 (0.321%)
Market Cap: £1.15b
VLX Live PriceLast checked at - London Stock Exchange

Intraday Volex Share Chart

Trading Update

15 Oct 2020 07:00

RNS Number : 1183C
Volex PLC
15 October 2020
 

15 October 2020

 

Volex plc

("Volex" or the "Company")

 

Trading Update

 

Volex plc (AIM:VLX), the global supplier of integrated manufacturing services and power products, is today issuing a trading update ahead of the scheduled announcement of the group's interim results for the 26 weeks ended 4 October 2020, on 12 November 2020. 

COVID-19

 

We are continuing to monitor the global situation in respect of COVID-19. The health, safety and well-being of our colleagues remain our principal responsibility and we are providing our facilities with our full support, following all public health advice, and complying with all government directives. All manufacturing facilities remained fully operational following adaptations that were made in the first quarter in response to the COVID-19 pandemic.

 

Trading

 

Volex's performance has continued to improve since the group last updated the market at our Annual General Meeting on 30 July 2020.

 

Consequently, the board now expects revenue and profitability to be above current market expectations for both the half-year period and the full year as a whole.

 

· Unaudited revenue for the six months ended 4 October 2020 is expected to be at least $200 million, which represents an increase of 2.2 per cent over the same period a year earlier;

 

· Underlying operating profit is expected to be at least $20 million, which represents an increase of 25.8 per cent over the same period a year earlier;

 

· Net cash excluding lease liabilities as at 2 October 2020 was approximately $31 million.

 

Executive Chairman Nat Rothschild commented:

 

"We enter the final quarter of calendar 2020 in a healthy position. Our geographic and customer diversification continues to provide the business with a high degree of visibility at this time while ongoing demand for consumer electronics remains strong and the global shift to electric vehicles gathers pace.

 

Absent another widespread COVID-19 related global lockdown, given the robust performance in the first half of the year, coupled with our strong forward order book position, the board expects to see a strong performance for the year as a whole that will be above current market expectations.

 

I would like to extend my sincere thanks to the entire Volex team for their invaluable contribution to this strong performance as we look ahead to the second half of the year with cautious optimism." 

 

For further information please contact:

 

Volex plc

+44 (0)7909 995 887

Nat Rothschild, Executive Chairman

 

Daren Morris, Chief Financial Officer

 

 

Powerscourt - Media Enquiries

+44 (0)20 7250 1446

James White

 

Jack Holden

 

 

N+1 Singer - Nominated Adviser & Joint Broker

+44 (0)20 7496 3000

Shaun Dobson

 

Iqra Amin

 

 

Panmure Gordon - Joint Broker

+44 (0)20 7886 2500

Hugh Rich

 

Nick Lovering

 

 

 

NOTES TO EDITORS:

Volex plc (AIM:VLX) is a leading integrated manufacturing specialist. The Group designs and manufactures products that ensure a critical connection never fails and are used in everything from defibrillators and ventilators through to data networking equipment and vehicle telematics. Headquartered in the United Kingdom, Volex serves the needs of its blue-chip customer base from its manufacturing sites located across nine countries and three continents, employing over 6,000 people. Volex's products are sold through its own global sales force and through distributors to Original Equipment Manufacturers ('OEMs') and Electronic Manufacturing Services companies. For more information please visit www.volex.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFFEFILESSEIS
Date   Source Headline
6th Aug 200811:13 amRNSHolding(s) in Company
24th Jul 200812:05 pmRNSResult of AGM
23rd Jul 20087:00 amRNSAGM & Interim Management Stat
11th Jul 20083:23 pmRNSDirector/PDMR Shareholding
11th Jul 20083:21 pmRNSDirector/PDMR Shareholding
11th Jul 20083:19 pmRNSDirector/PDMR Shareholding
2nd Jul 200811:02 amRNSHolding(s) in Company
9th Jun 20087:00 amRNSFinal Results
28th May 200810:16 amRNSNotice of Results
27th May 20087:00 amRNSDirectorate Change
1st May 20089:50 amRNSHolding(s) in Company
18th Apr 20081:00 pmRNSHolding(s) in Company
17th Apr 20084:29 pmRNSHolding(s) in Company
10th Apr 200811:53 amRNSBlocklisting Interim Review
10th Apr 200811:40 amRNSBlocklisting Interim Review
1st Apr 200812:09 pmRNSHolding(s) in Company
13th Mar 200811:42 amRNSHolding(s) in Company
10th Mar 20087:44 amRNSTrading Statement
3rd Mar 20089:48 amRNSHolding(s) in Company
18th Feb 20083:09 pmRNSDirector/PDMR Shareholding
15th Feb 20087:00 amRNSInterim Management Statement
1st Feb 20083:12 pmRNSHolding(s) in Company
29th Jan 20083:59 pmRNSTrading Update
24th Jan 200812:57 pmRNSDirectorate Change
23rd Jan 20085:02 pmRNSDirectorate Change
10th Jan 200812:30 pmRNSDirectorate Change
19th Dec 20073:26 pmRNSHolding(s) in Company
6th Dec 200711:16 amRNSHolding(s) in Company
12th Nov 20077:00 amRNSInterim Results
1st Nov 20073:36 pmRNSHolding(s) in Company
31st Oct 20071:51 pmRNSHolding(s) in Company
17th Oct 20074:49 pmRNSBlocklisting Interim Review
17th Oct 20074:48 pmRNSBlocklisting Interim Review
17th Oct 20074:48 pmRNSBlocklisting Interim Review
5th Oct 200712:10 pmRNSHolding(s) in Company
26th Sep 20073:25 pmRNSDirector/PDMR Shareholding
24th Sep 20079:41 amRNSHolding(s) in Company
24th Sep 20079:24 amRNSNotice of Results
28th Aug 200711:27 amRNSHolding(s) in Company
17th Aug 20073:12 pmRNSHolding(s) in Company
13th Aug 200711:03 amRNSAnnual Information Update
2nd Aug 200710:22 amRNSDirector/PDMR Shareholding
24th Jul 20074:29 pmRNSResult of AGM
24th Jul 20074:25 pmRNSHolding(s) in Company
24th Jul 20074:21 pmRNSHolding(s) in Company
24th Jul 20074:18 pmRNSHolding(s) in Company
24th Jul 20077:00 amRNSInterim Management Statement
19th Jul 20072:39 pmRNSHolding(s) in Company
6th Jul 20072:16 pmRNSHolding(s) in Company
29th Jun 20073:55 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.